APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Malaria Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Malaria Vaccines Industry Growth and Trends Forecast to 2032

Report ID 174009990122 December 2025124 pages

Choose your research edition.

Industry ResearchMalaria Vaccines Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Malaria Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Malaria Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Malaria Vaccines Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Malaria Vaccines Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

According to APO Research, the global Malaria Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Malaria Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Malaria Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Malaria Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Malaria Vaccines market include Sanofi, Novartis AG, Mylan N.V., Pfizer Inc, GlaxoSmithKline Plc, Zydus Cadila, VLP Therapeutics, Taj Pharmaceuticals Limited and Sun Pharmaceutical Industries Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Malaria Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Malaria Vaccines market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Malaria Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Malaria Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Malaria Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Malaria Vaccines Market by Company

Sanofi

Novartis AG

Mylan N.V.

Pfizer Inc

GlaxoSmithKline Plc

Zydus Cadila

VLP Therapeutics

Taj Pharmaceuticals Limited

Sun Pharmaceutical Industries Ltd

Sumaya Biotech

Strides Pharma Science Limited

Sanaria Inc

OSIVAX

Nobelpharma Co

Lupin

Ipca Laboratories Ltd

Hikma Pharmaceuticals PLC

GeoVax

GenVec

Cipla Inc

CellFree Sciences

Bliss GVS Pharma Ltd

Amneal Pharmaceuticals LLC

AJANTA PHARMA

AdvaCare Pharma

Actiza Pharmaceutical Private Limited

Malaria Vaccines Segment by Type

Erythrocytic Vaccine

Pre-Erythrocytic Vaccine

Multi-antigen Vaccine

Malaria Vaccines Segment by Application

Clinics

Hospitals

Community Centers

Malaria Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Malaria Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Malaria Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Malaria Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Malaria Vaccines companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Malaria Vaccines Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Malaria Vaccines Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Malaria Vaccines Market Share by Region (2021-2026) Table 4. Global Malaria Vaccines Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Malaria Vaccines Market Share by Region (2027-2032) Table 6. Global Malaria Vaccines Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Malaria Vaccines Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Malaria Vaccines Market Size Share by Type (2021-2026) Table 9. Global Malaria Vaccines Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Malaria Vaccines Market Size Share Forecasted by Type (2027-2032) Table 11. North America Malaria Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Malaria Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Malaria Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Malaria Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Malaria Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Malaria Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Malaria Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Malaria Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Malaria Vaccines Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Malaria Vaccines Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Malaria Vaccines Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Malaria Vaccines Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Malaria Vaccines Market Size Share by Application (2021-2026) Table 24. Global Malaria Vaccines Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Malaria Vaccines Market Size Share Forecasted by Application (2027-2032) Table 26. North America Malaria Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Malaria Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Malaria Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Malaria Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Malaria Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Malaria Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Malaria Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Malaria Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Malaria Vaccines Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Malaria Vaccines Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Malaria Vaccines Industry Trends Table 37. Malaria Vaccines Industry Drivers Table 38. Malaria Vaccines Industry Opportunities and Challenges Table 39. Malaria Vaccines Industry Restraints Table 40. Global Malaria Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Malaria Vaccines Revenue Market Share by Company (2021-2026) Table 42. Global Malaria Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Malaria Vaccines Key Company Headquarters & Area Served Table 44. Global Malaria Vaccines Company, Product Type & Application Table 45. Global Malaria Vaccines Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Malaria Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Malaria Vaccines Product Portfolio Table 52. Sanofi Recent Development Table 53. Novartis AG Company Information Table 54. Novartis AG Business Overview Table 55. Novartis AG Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Novartis AG Malaria Vaccines Product Portfolio Table 57. Novartis AG Recent Development Table 58. Mylan N.V. Company Information Table 59. Mylan N.V. Business Overview Table 60. Mylan N.V. Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Mylan N.V. Malaria Vaccines Product Portfolio Table 62. Mylan N.V. Recent Development Table 63. Pfizer Inc Company Information Table 64. Pfizer Inc Business Overview Table 65. Pfizer Inc Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Pfizer Inc Malaria Vaccines Product Portfolio Table 67. Pfizer Inc Recent Development Table 68. GlaxoSmithKline Plc Company Information Table 69. GlaxoSmithKline Plc Business Overview Table 70. GlaxoSmithKline Plc Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline Plc Malaria Vaccines Product Portfolio Table 72. GlaxoSmithKline Plc Recent Development Table 73. Zydus Cadila Company Information Table 74. Zydus Cadila Business Overview Table 75. Zydus Cadila Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Zydus Cadila Malaria Vaccines Product Portfolio Table 77. Zydus Cadila Recent Development Table 78. VLP Therapeutics Company Information Table 79. VLP Therapeutics Business Overview Table 80. VLP Therapeutics Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. VLP Therapeutics Malaria Vaccines Product Portfolio Table 82. VLP Therapeutics Recent Development Table 83. Taj Pharmaceuticals Limited Company Information Table 84. Taj Pharmaceuticals Limited Business Overview Table 85. Taj Pharmaceuticals Limited Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Taj Pharmaceuticals Limited Malaria Vaccines Product Portfolio Table 87. Taj Pharmaceuticals Limited Recent Development Table 88. Sun Pharmaceutical Industries Ltd Company Information Table 89. Sun Pharmaceutical Industries Ltd Business Overview Table 90. Sun Pharmaceutical Industries Ltd Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Portfolio Table 92. Sun Pharmaceutical Industries Ltd Recent Development Table 93. Sumaya Biotech Company Information Table 94. Sumaya Biotech Business Overview Table 95. Sumaya Biotech Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Sumaya Biotech Malaria Vaccines Product Portfolio Table 97. Sumaya Biotech Recent Development Table 98. Strides Pharma Science Limited Company Information Table 99. Strides Pharma Science Limited Business Overview Table 100. Strides Pharma Science Limited Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Strides Pharma Science Limited Malaria Vaccines Product Portfolio Table 102. Strides Pharma Science Limited Recent Development Table 103. Sanaria Inc Company Information Table 104. Sanaria Inc Business Overview Table 105. Sanaria Inc Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Sanaria Inc Malaria Vaccines Product Portfolio Table 107. Sanaria Inc Recent Development Table 108. OSIVAX Company Information Table 109. OSIVAX Business Overview Table 110. OSIVAX Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. OSIVAX Malaria Vaccines Product Portfolio Table 112. OSIVAX Recent Development Table 113. Nobelpharma Co Company Information Table 114. Nobelpharma Co Business Overview Table 115. Nobelpharma Co Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Nobelpharma Co Malaria Vaccines Product Portfolio Table 117. Nobelpharma Co Recent Development Table 118. Lupin Company Information Table 119. Lupin Business Overview Table 120. Lupin Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Lupin Malaria Vaccines Product Portfolio Table 122. Lupin Recent Development Table 123. Ipca Laboratories Ltd Company Information Table 124. Ipca Laboratories Ltd Business Overview Table 125. Ipca Laboratories Ltd Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Ipca Laboratories Ltd Malaria Vaccines Product Portfolio Table 127. Ipca Laboratories Ltd Recent Development Table 128. Hikma Pharmaceuticals PLC Company Information Table 129. Hikma Pharmaceuticals PLC Business Overview Table 130. Hikma Pharmaceuticals PLC Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Hikma Pharmaceuticals PLC Malaria Vaccines Product Portfolio Table 132. Hikma Pharmaceuticals PLC Recent Development Table 133. GeoVax Company Information Table 134. GeoVax Business Overview Table 135. GeoVax Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. GeoVax Malaria Vaccines Product Portfolio Table 137. GeoVax Recent Development Table 138. GenVec Company Information Table 139. GenVec Business Overview Table 140. GenVec Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. GenVec Malaria Vaccines Product Portfolio Table 142. GenVec Recent Development Table 143. Cipla Inc Company Information Table 144. Cipla Inc Business Overview Table 145. Cipla Inc Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Cipla Inc Malaria Vaccines Product Portfolio Table 147. Cipla Inc Recent Development Table 148. CellFree Sciences Company Information Table 149. CellFree Sciences Business Overview Table 150. CellFree Sciences Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. CellFree Sciences Malaria Vaccines Product Portfolio Table 152. CellFree Sciences Recent Development Table 153. Bliss GVS Pharma Ltd Company Information Table 154. Bliss GVS Pharma Ltd Business Overview Table 155. Bliss GVS Pharma Ltd Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Bliss GVS Pharma Ltd Malaria Vaccines Product Portfolio Table 157. Bliss GVS Pharma Ltd Recent Development Table 158. Amneal Pharmaceuticals LLC Company Information Table 159. Amneal Pharmaceuticals LLC Business Overview Table 160. Amneal Pharmaceuticals LLC Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Amneal Pharmaceuticals LLC Malaria Vaccines Product Portfolio Table 162. Amneal Pharmaceuticals LLC Recent Development Table 163. AJANTA PHARMA Company Information Table 164. AJANTA PHARMA Business Overview Table 165. AJANTA PHARMA Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. AJANTA PHARMA Malaria Vaccines Product Portfolio Table 167. AJANTA PHARMA Recent Development Table 168. AdvaCare Pharma Company Information Table 169. AdvaCare Pharma Business Overview Table 170. AdvaCare Pharma Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. AdvaCare Pharma Malaria Vaccines Product Portfolio Table 172. AdvaCare Pharma Recent Development Table 173. Actiza Pharmaceutical Private Limited Company Information Table 174. Actiza Pharmaceutical Private Limited Business Overview Table 175. Actiza Pharmaceutical Private Limited Malaria Vaccines Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Actiza Pharmaceutical Private Limited Malaria Vaccines Product Portfolio Table 177. Actiza Pharmaceutical Private Limited Recent Development Table 178. North America Malaria Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. North America Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 180. North America Malaria Vaccines Market Share by Country (2021-2026) Table 181. North America Malaria Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. North America Malaria Vaccines Market Share Forecast by Country (2027-2032) Table 183. Europe Malaria Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Europe Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 185. Europe Malaria Vaccines Market Share by Country (2021-2026) Table 186. Europe Malaria Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Europe Malaria Vaccines Market Share Forecast by Country (2027-2032) Table 188. Asia-Pacific Malaria Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Asia-Pacific Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 190. Asia-Pacific Malaria Vaccines Market Share by Country (2021-2026) Table 191. Asia-Pacific Malaria Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Asia-Pacific Malaria Vaccines Market Share Forecast by Country (2027-2032) Table 193. Latin America Malaria Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Malaria Vaccines Market Share by Country (2021-2026) Table 196. Latin America Malaria Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Malaria Vaccines Market Share Forecast by Country (2027-2032) Table 198. Middle East & Africa Malaria Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East & Africa Malaria Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East & Africa Malaria Vaccines Market Share by Country (2021-2026) Table 201. Middle East & Africa Malaria Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East & Africa Malaria Vaccines Market Share Forecast by Country (2027-2032) Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Malaria Vaccines Product Image Figure 3. Global Malaria Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Malaria Vaccines Market Size (2021-2032) & (US$ Million) Figure 5. Global Malaria Vaccines Market Share by Region: 2025 VS 2032 Figure 6. Global Malaria Vaccines Market Share by Region (2021-2032) Figure 7. North America Malaria Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Malaria Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Malaria Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Malaria Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Malaria Vaccines Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Erythrocytic Vaccine Image Figure 13. Global Erythrocytic Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Pre-Erythrocytic Vaccine Image Figure 15. Global Pre-Erythrocytic Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Multi-antigen Vaccine Image Figure 17. Global Multi-antigen Vaccine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Global Malaria Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 19. Global Malaria Vaccines Market Share by Type 2025 VS 2032 Figure 20. North America Malaria Vaccines Market Size Share by Type (2021-2032) Figure 21. Europe Malaria Vaccines Market Size Share by Type (2021-2032) Figure 22. Asia-Pacific Malaria Vaccines Market Size Share by Type (2021-2032) Figure 23. Latin America Malaria Vaccines Market Size Share by Type (2021-2032) Figure 24. Middle East and Africa Malaria Vaccines Market Size Share by Type (2021-2032) Figure 25. Clinics Image Figure 26. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Hospitals Image Figure 28. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Community Centers Image Figure 30. Global Community Centers Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Malaria Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Malaria Vaccines Market Share by Application 2025 VS 2032 Figure 33. North America Malaria Vaccines Market Size Share by Application (2021-2032) Figure 34. Europe Malaria Vaccines Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Malaria Vaccines Market Size Share by Application (2021-2032) Figure 36. Latin America Malaria Vaccines Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Malaria Vaccines Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Malaria Vaccines Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Malaria Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Malaria Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Malaria Vaccines Market Share by Country (2021-2032) Figure 43. Europe Malaria Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Malaria Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Malaria Vaccines Market Share by Country (2021-2032) Figure 46. Asia-Pacific Malaria Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Malaria Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Malaria Vaccines Market Share by Country (2021-2032) Figure 49. Latin America Malaria Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Malaria Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Malaria Vaccines Market Share by Country (2021-2032) Figure 52. Middle East & Africa Malaria Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Malaria Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Malaria Vaccines Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Erythrocytic Vaccine
  • Pre-Erythrocytic Vaccine
  • Multi-antigen Vaccine
Applications
  • Clinics
  • Hospitals
  • Community Centers
Companies covered
  • Sanofi
  • Novartis AG
  • Mylan N.V.
  • Pfizer Inc
  • GlaxoSmithKline Plc
  • Zydus Cadila
  • VLP Therapeutics
  • Taj Pharmaceuticals Limited
  • Sun Pharmaceutical Industries Ltd
  • Sumaya Biotech
  • Strides Pharma Science Limited
  • Sanaria Inc
  • OSIVAX
  • Nobelpharma Co
  • Lupin
  • Ipca Laboratories Ltd
  • Hikma Pharmaceuticals PLC
  • GeoVax
  • GenVec
  • Cipla Inc
  • CellFree Sciences
  • Bliss GVS Pharma Ltd
  • Amneal Pharmaceuticals LLC
  • AJANTA PHARMA
  • AdvaCare Pharma
  • Actiza Pharmaceutical Private Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Malaria Vaccines Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Malaria Vaccines Market Size by Region (2021-2032)
  5. 1.4.1 Global Malaria Vaccines Market Size by Region (2021-2026)
  6. 1.4.2 Global Malaria Vaccines Market Size by Region (2027-2032)
  7. 1.5 Key Regions Malaria Vaccines Market Size (2021-2032)
  8. 1.5.1 North America Malaria Vaccines Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Malaria Vaccines Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Malaria Vaccines Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Malaria Vaccines Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Malaria Vaccines Market Size Growth Rate (2021-2032)
2 Malaria Vaccines Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Erythrocytic Vaccine
  3. 2.1.2 Pre-Erythrocytic Vaccine
  4. 2.1.3 Multi-antigen Vaccine
  5. 2.2 Global Malaria Vaccines Market Size by Type
  6. 2.2.1 Global Malaria Vaccines Market Size Overview by Type (2021-2032)
  7. 2.2.2 Global Malaria Vaccines Historic Market Size Review by Type (2021-2026)
  8. 2.2.3 Global Malaria Vaccines Market Size Forecasted by Type (2027-2032)
  9. 2.3 Global Malaria Vaccines Market Size by Regions
  10. 2.3.1 North America Malaria Vaccines Market Size Breakdown by Type (2021-2026)
  11. 2.3.2 Europe Malaria Vaccines Market Size Breakdown by Type (2021-2026)
  12. 2.3.3 Asia-Pacific Malaria Vaccines Market Size Breakdown by Type (2021-2026)
  13. 2.3.4 South America Malaria Vaccines Market Size Breakdown by Type (2021-2026)
  14. 2.3.5 Middle East and Africa Malaria Vaccines Market Size Breakdown by Type (2021-2026)
3 Malaria Vaccines Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Clinics
  3. 3.1.2 Hospitals
  4. 3.1.3 Community Centers
  5. 3.2 Global Malaria Vaccines Market Size by Application
  6. 3.2.1 Global Malaria Vaccines Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Malaria Vaccines Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Malaria Vaccines Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Malaria Vaccines Market Size by Regions
  10. 3.3.1 North America Malaria Vaccines Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Malaria Vaccines Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Malaria Vaccines Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Malaria Vaccines Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Malaria Vaccines Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Malaria Vaccines Industry Trends
  2. 4.2 Malaria Vaccines Industry Drivers
  3. 4.3 Malaria Vaccines Industry Opportunities and Challenges
  4. 4.4 Malaria Vaccines Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Malaria Vaccines Revenue (2021-2026)
  2. 5.2 Global Malaria Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Malaria Vaccines Key Company Headquarters & Area Served
  4. 5.4 Global Malaria Vaccines Company, Product Type & Application
  5. 5.5 Global Malaria Vaccines Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Malaria Vaccines Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Malaria Vaccines Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Malaria Vaccines Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Malaria Vaccines Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Novartis AG
  8. 6.2.1 Novartis AG Company Information
  9. 6.2.2 Novartis AG Business Overview
  10. 6.2.3 Novartis AG Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Novartis AG Malaria Vaccines Product Portfolio
  12. 6.2.5 Novartis AG Recent Developments
  13. 6.3 Mylan N.V.
  14. 6.3.1 Mylan N.V. Company Information
  15. 6.3.2 Mylan N.V. Business Overview
  16. 6.3.3 Mylan N.V. Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Mylan N.V. Malaria Vaccines Product Portfolio
  18. 6.3.5 Mylan N.V. Recent Developments
  19. 6.4 Pfizer Inc
  20. 6.4.1 Pfizer Inc Company Information
  21. 6.4.2 Pfizer Inc Business Overview
  22. 6.4.3 Pfizer Inc Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Inc Malaria Vaccines Product Portfolio
  24. 6.4.5 Pfizer Inc Recent Developments
  25. 6.5 GlaxoSmithKline Plc
  26. 6.5.1 GlaxoSmithKline Plc Company Information
  27. 6.5.2 GlaxoSmithKline Plc Business Overview
  28. 6.5.3 GlaxoSmithKline Plc Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Plc Malaria Vaccines Product Portfolio
  30. 6.5.5 GlaxoSmithKline Plc Recent Developments
  31. 6.6 Zydus Cadila
  32. 6.6.1 Zydus Cadila Company Information
  33. 6.6.2 Zydus Cadila Business Overview
  34. 6.6.3 Zydus Cadila Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Zydus Cadila Malaria Vaccines Product Portfolio
  36. 6.6.5 Zydus Cadila Recent Developments
  37. 6.7 VLP Therapeutics
  38. 6.7.1 VLP Therapeutics Company Information
  39. 6.7.2 VLP Therapeutics Business Overview
  40. 6.7.3 VLP Therapeutics Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 VLP Therapeutics Malaria Vaccines Product Portfolio
  42. 6.7.5 VLP Therapeutics Recent Developments
  43. 6.8 Taj Pharmaceuticals Limited
  44. 6.8.1 Taj Pharmaceuticals Limited Company Information
  45. 6.8.2 Taj Pharmaceuticals Limited Business Overview
  46. 6.8.3 Taj Pharmaceuticals Limited Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Taj Pharmaceuticals Limited Malaria Vaccines Product Portfolio
  48. 6.8.5 Taj Pharmaceuticals Limited Recent Developments
  49. 6.9 Sun Pharmaceutical Industries Ltd
  50. 6.9.1 Sun Pharmaceutical Industries Ltd Company Information
  51. 6.9.2 Sun Pharmaceutical Industries Ltd Business Overview
  52. 6.9.3 Sun Pharmaceutical Industries Ltd Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sun Pharmaceutical Industries Ltd Malaria Vaccines Product Portfolio
  54. 6.9.5 Sun Pharmaceutical Industries Ltd Recent Developments
  55. 6.10 Sumaya Biotech
  56. 6.10.1 Sumaya Biotech Company Information
  57. 6.10.2 Sumaya Biotech Business Overview
  58. 6.10.3 Sumaya Biotech Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Sumaya Biotech Malaria Vaccines Product Portfolio
  60. 6.10.5 Sumaya Biotech Recent Developments
  61. 6.11 Strides Pharma Science Limited
  62. 6.11.1 Strides Pharma Science Limited Company Information
  63. 6.11.2 Strides Pharma Science Limited Business Overview
  64. 6.11.3 Strides Pharma Science Limited Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Strides Pharma Science Limited Malaria Vaccines Product Portfolio
  66. 6.11.5 Strides Pharma Science Limited Recent Developments
  67. 6.12 Sanaria Inc
  68. 6.12.1 Sanaria Inc Company Information
  69. 6.12.2 Sanaria Inc Business Overview
  70. 6.12.3 Sanaria Inc Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Sanaria Inc Malaria Vaccines Product Portfolio
  72. 6.12.5 Sanaria Inc Recent Developments
  73. 6.13 OSIVAX
  74. 6.13.1 OSIVAX Company Information
  75. 6.13.2 OSIVAX Business Overview
  76. 6.13.3 OSIVAX Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 OSIVAX Malaria Vaccines Product Portfolio
  78. 6.13.5 OSIVAX Recent Developments
  79. 6.14 Nobelpharma Co
  80. 6.14.1 Nobelpharma Co Company Information
  81. 6.14.2 Nobelpharma Co Business Overview
  82. 6.14.3 Nobelpharma Co Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Nobelpharma Co Malaria Vaccines Product Portfolio
  84. 6.14.5 Nobelpharma Co Recent Developments
  85. 6.15 Lupin
  86. 6.15.1 Lupin Company Information
  87. 6.15.2 Lupin Business Overview
  88. 6.15.3 Lupin Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Lupin Malaria Vaccines Product Portfolio
  90. 6.15.5 Lupin Recent Developments
  91. 6.16 Ipca Laboratories Ltd
  92. 6.16.1 Ipca Laboratories Ltd Company Information
  93. 6.16.2 Ipca Laboratories Ltd Business Overview
  94. 6.16.3 Ipca Laboratories Ltd Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Ipca Laboratories Ltd Malaria Vaccines Product Portfolio
  96. 6.16.5 Ipca Laboratories Ltd Recent Developments
  97. 6.17 Hikma Pharmaceuticals PLC
  98. 6.17.1 Hikma Pharmaceuticals PLC Company Information
  99. 6.17.2 Hikma Pharmaceuticals PLC Business Overview
  100. 6.17.3 Hikma Pharmaceuticals PLC Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Hikma Pharmaceuticals PLC Malaria Vaccines Product Portfolio
  102. 6.17.5 Hikma Pharmaceuticals PLC Recent Developments
  103. 6.18 GeoVax
  104. 6.18.1 GeoVax Company Information
  105. 6.18.2 GeoVax Business Overview
  106. 6.18.3 GeoVax Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 GeoVax Malaria Vaccines Product Portfolio
  108. 6.18.5 GeoVax Recent Developments
  109. 6.19 GenVec
  110. 6.19.1 GenVec Company Information
  111. 6.19.2 GenVec Business Overview
  112. 6.19.3 GenVec Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 GenVec Malaria Vaccines Product Portfolio
  114. 6.19.5 GenVec Recent Developments
  115. 6.20 Cipla Inc
  116. 6.20.1 Cipla Inc Company Information
  117. 6.20.2 Cipla Inc Business Overview
  118. 6.20.3 Cipla Inc Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Cipla Inc Malaria Vaccines Product Portfolio
  120. 6.20.5 Cipla Inc Recent Developments
  121. 6.21 CellFree Sciences
  122. 6.21.1 CellFree Sciences Company Information
  123. 6.21.2 CellFree Sciences Business Overview
  124. 6.21.3 CellFree Sciences Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 CellFree Sciences Malaria Vaccines Product Portfolio
  126. 6.21.5 CellFree Sciences Recent Developments
  127. 6.22 Bliss GVS Pharma Ltd
  128. 6.22.1 Bliss GVS Pharma Ltd Company Information
  129. 6.22.2 Bliss GVS Pharma Ltd Business Overview
  130. 6.22.3 Bliss GVS Pharma Ltd Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Bliss GVS Pharma Ltd Malaria Vaccines Product Portfolio
  132. 6.22.5 Bliss GVS Pharma Ltd Recent Developments
  133. 6.23 Amneal Pharmaceuticals LLC
  134. 6.23.1 Amneal Pharmaceuticals LLC Company Information
  135. 6.23.2 Amneal Pharmaceuticals LLC Business Overview
  136. 6.23.3 Amneal Pharmaceuticals LLC Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Amneal Pharmaceuticals LLC Malaria Vaccines Product Portfolio
  138. 6.23.5 Amneal Pharmaceuticals LLC Recent Developments
  139. 6.24 AJANTA PHARMA
  140. 6.24.1 AJANTA PHARMA Company Information
  141. 6.24.2 AJANTA PHARMA Business Overview
  142. 6.24.3 AJANTA PHARMA Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 AJANTA PHARMA Malaria Vaccines Product Portfolio
  144. 6.24.5 AJANTA PHARMA Recent Developments
  145. 6.25 AdvaCare Pharma
  146. 6.25.1 AdvaCare Pharma Company Information
  147. 6.25.2 AdvaCare Pharma Business Overview
  148. 6.25.3 AdvaCare Pharma Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 AdvaCare Pharma Malaria Vaccines Product Portfolio
  150. 6.25.5 AdvaCare Pharma Recent Developments
  151. 6.26 Actiza Pharmaceutical Private Limited
  152. 6.26.1 Actiza Pharmaceutical Private Limited Company Information
  153. 6.26.2 Actiza Pharmaceutical Private Limited Business Overview
  154. 6.26.3 Actiza Pharmaceutical Private Limited Malaria Vaccines Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Actiza Pharmaceutical Private Limited Malaria Vaccines Product Portfolio
  156. 6.26.5 Actiza Pharmaceutical Private Limited Recent Developments
7 North America
  1. 7.1 North America Malaria Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Malaria Vaccines Market Size by Country (2021-2026)
  3. 7.3 North America Malaria Vaccines Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Malaria Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Malaria Vaccines Market Size by Country (2021-2026)
  3. 8.3 Europe Malaria Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Malaria Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Malaria Vaccines Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Malaria Vaccines Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Malaria Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Malaria Vaccines Market Size by Country (2021-2026)
  3. 10.3 South America Malaria Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Malaria Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Malaria Vaccines Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Malaria Vaccines Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst